Stay updated on Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page.

Latest updates to the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed interface revision/version updates from v3.5.2 to v3.5.3, reflecting a change to the site tooling rather than the underlying trial record content.SummaryDifference0.1%

- Check9 days agoChange DetectedA new revision, v3.5.2, has been added to the history, replacing the previous v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Study Design, Study Status, and Document Section. Also updated the record with a Quality Control status note 'Has Not Concluded' and a version update to 3.5.0 (2026-02-25).SummaryDifference1%

- Check45 days agoChange DetectedRevision: v3.4.3 added; Revision: v3.4.2 removed.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded 'Results Submitted' to the record history and removed 'No Results Posted'.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 label was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page.